Seminars in Nephrology
Volume 29, Issue 4 , Pages 338-348 , July 2009

Genetic Testing: Considerations for Pediatric Nephrologists

  • Lisa M. Guay-Woodford, MD

      Affiliations

    • Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
    • Corresponding Author InformationAddress reprint requests to Lisa M. Guay-Woodford, MD, Pediatric Nephrologist, Professor and Vice Chair, Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005
    • ,
  • Nine V.A.M. Knoers, MD, PhD

      Affiliations

    • Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

References 

  1. Robin NH, Tabereaux PB, Benza R, Korf BR. Genetic testing in cardiovascular disease. J Am Coll Cardiol. 2007;50:727–737
  2. Brockmoller J, Tzvetkov MV. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Eur J Clin Pharmacol. 2008;64:133–157
  3. Korf BR. Genetic testing and medical practice. Curr Opin Pediatr. 2001;13:547–549
  4. The International HapMap Consortium. The international HapMap project. Nature. 2003;426:789–796
  5. Altshuler D, Brooks L, Chakravarti A, Collins F, Daly M, Donnelly P International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–1320
  6. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing?. Genet Med. 2006;8:448–450
  7. Ethical, legal and social implications of genetic testing. Bull Med Ethics. 2004;9–11
  8. Lissemore JL. Linkage of genetics and ethics: more crossing over is needed. Biol Cell. 2005;97:599–604
  9. Sanderson S, Zimmern R, Kroese M, Higgins J, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? (Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom). Genet Med. 2005;7:495–500
  10. Hodges JG. Ethical issues concerning genetic testing and screening in public health. Am J Med Genet C Semin Med Genet. 2004;125C:66–70
  11. Fraser FC. Genetic counseling. Am J Hum Genet. 1974;26:636–661
  12. Kakuk P. Gene concepts and genethics: beyond exceptionalism. Sci Eng Ethics. 2008;14:357–375
  13. Minkoff H, Ecker J. Genetic testing and breach of patient confidentiality: law, ethics, and pragmatics. Am J Obstet Gynecol. 2008;498:e1–e4
  14. Borry P, Goffin T, Nys H, Dierickx K. Attitudes regarding predictive genetic testing in minors: a survey of European clinical geneticists. Am J Med Genet C Semin Med Genet. 2008;148:78–83
  15. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature. 2003;422:835–847
  16. Tatsioni A, Zarin DA, Aronson N, Samson DJ, Flamm CR, Schmid C, et al. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med. 2005;142:1048–1055
  17. Ball RH. Invasive fetal testing. Curr Opin Obstet Gynecol. 2005;16:159–162
  18. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol. 2007;110:687–694
  19. Sekizawa A, Purwosunu Y, Matsuoka R, Koide K, Okazaki S, Farina A, et al. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. J Obstet Gynaecol Res. 2007;33:747–764
  20. Steinbock B. Prenatal testing for adult-onset conditions: cui bono?. Reprod Biomed Online. 2007;15(Suppl 2):38–42
  21. Wilfond B ASHG Social Issues Committee. Ethical, legal, and psychosocial implications of genetic testing in children and adolescents (ACMG/ASHG Report). Am J Hum Genet. 1995;57:1233–1241
  22. Fragouli E. Preimplantation genetic diagnosis: present and future. J Assist Reprod Genet. 2007;24:201–207
  23. Peng W, Takabayashi H, Ikawa K. Whole genome amplification from single cells in preimplantation genetic diagnosis and prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol. 2007;131:13–20
  24. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30:259–269
  25. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet. 2002;70:1305–1317
  26. Adeva M, El-Youssef M, Rossetti S, Kamath P, Kubly V, Consugar M, et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore). 2006;85:1–21
  27. Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal recessive polycystic kidney disease (ARPKD). Kidney Int. 2005;67:829–848
  28. Sharp AM, Messiaen LM, Page G, Antignac C, Gubler M-C, Onuchic LF, et al. Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts. J Med Genet. 2005;42:336–349
  29. Losekoot M, Haarlo C, Ruivenkamp C, White SJ, Breuning MH, Peters DJ. Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD). Hum Genet. 2005;188:185–206
  30. Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Kunze J, Mononen T, et al. New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene. Clin Genet. 2004;66:53–57
  31. Gigarel N, Frydman N, Burlet P, Kerbrat V, Tachdjian G, Fanchin R, et al. Preimplantation genetic diagnosis for autosomal recessive polycystic kidney disease. Reprod Biomed Online. 2008;16:152–158
  32. Bergmann C, Senderek J, Sedlacek B, Pegiazoglou I, Puglia P, Eggermann T, et al. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol. 2003;14:76–89
  33. Deget F, Rudnik-Schoneborn S, Zerres K. Course of autosomal recessive polycystic kidney disease (ARPKD) in siblings: a clinical comparison of 20 sibships. Clin Genet. 1995;47:248–253
  34. Kaplan BS, Kaplan P, de Chadarevian JP, Jequier S, O'Regan S, Russo P. Variable expression of autosomal recessive polycystic kidney disease and congenital hepatic fibrosis within a family. Am J Med Genet. 1988;29:639–647
  35. Karle S, Uetz B, Ronner V, Glaese L, Hildebrandt F, Fuchshuber A, et al. Novel mutations in NPHS2 are detected in familial as well as sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2002;13:388–393
  36. Caridi G, Berdeli A, Dagnino M, Di Duca M, Mir S, Cura A, et al. Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin. Am J Kidney Dis. 2004;43:727–732
  37. Weber S, Gribouval O, Esquivel E, Moriniere V, Tete M, Legendre C, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 2004;66:571–579
  38. Ruf R, Schultheiss M, Lichtenberger A, Karle S, Zalewski I, Mucha B, et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int. 2004;66:564–570
  39. Yao J, Le T, Kos C, Henderson J, Allen P, Denker B, et al. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol. 2004;2:e167
  40. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 2005;308:1801–1804
  41. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest. 2002;110:1659–1666
  42. Aucella F, De Bonis P, Gatta G, Muscarella L, Vigilante M, di Giorgio G, et al. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron Clin Pract. 2005;99:c31–c36
  43. Orloff M, Iyengar S, Winkler C, Goddard K, Dart R, Ahuja T, et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics. 2005;21:212–221
  44. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629–639
  45. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis. 2003;41:1314–1321
  46. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol. 2004;15:722–732
  47. Cattran D. Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:234–241
  48. Ponticelli C, Passerini P. Other immunosuppressive agents for focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:242–248
  49. Schnaper H. Idiopathic focal segmental glomerulosclerosis. Semin Nephrol. 2003;23:183–193
  50. Niaudet P. Podocin and nephrotic syndrome: implications for the clinician. J Am Soc Nephrol. 2004;15:832–834
  51. Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess. 2007;11:iii-iv, ix-xi, 1-93
  52. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2008;19:365–371
  53. Daskalakis N, Winn MP. Focal and segmental glomerulosclerosis. Cell Mol Life Sci. 2006;63:2506–2511
  54. He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, et al. Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2007;2:31–37
  55. Deegens JK, Steenbergen EJ, Wetzels JF. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med. 2008;66:3–12
  56. Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol. 2001;16:1146–1152
  57. Bichet DG. Hereditary polyuric disorders: new concepts and differential diagnosis. Semin Nephrol. 2006;26:224–233
  58. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812–3814
  59. Herrgard S, Cammer SA, Hoffman BT, Knutson S, Gallina M, Speir JA, et al. Prediction of deleterious functional effects of amino acid mutations using a library of structure-based function descriptors. Proteins. 2003;53:806–816
  60. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics. 2004;83:970–979
  61. Balasubramanian S, Xia Y, Freinkman E, Gerstein M. Sequence variation in G-protein-coupled receptors: analysis of single nucleotide polymorphisms. Nucleic Acids Res. 2005;33:1710–1721
  62. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007;35:3823–3835
  63. Barenboim M, Masso M, Vaisman II, Jamison DC. Statistical geometry based prediction of nonsynonymous SNP functional effects using random forest and neuro-fuzzy classifiers. Proteins. 2008;71:1930–1939
  64. Sellner LN, Taylor GR. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat. 2004;23:413–419
  65. Bongers EM, de Wijs IJ, Marcelis C, Hoefsloot LH, Knoers NVAM. Identification of entire LMX1B gene deletions in nail patella syndrome: evidence for haploinsufficiency as the main pathogenic mechanism underlying dominant inheritance in man. Eur J Hum Genet. 2008;16:1240–1244
  66. Pinto D, Marshall C, Feuk L, Scherer SW. Copy-number variation in control population cohorts. Hum Mol Genet. 2007;16:R168–R173
  67. Kehrer-Sawatzki H. What a difference copy number variation makes. Bioessays. 2007;29:311–313
  68. Shelling AN, Ferguson LR. Genetic variation in human disease and a new role for copy number variants. Mutat Res. 2007;622:33–41
  69. Stone EM. Leber congenital amaurosis—a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 2007;144:791–811
  70. Hauss O, Muller O. The protein truncation test in mutation detection and molecular diagnosis. Methods Mol Biol. 2007;375:151–164
  71. Beaudet AL, Belmont JW. Array-based DNA diagnostics: let the revolution begin. Annu Rev Med. 2008;59:113–129
  72. Bentley DR. Whole-genome re-sequencing. Curr Opin Genet Dev. 2006;16:545–552
  73. Clayton E. Ethical, legal, and social implications of genomic medicine. N Engl J Med. 2003;349:562–569

PII: S0270-9295(09)00047-3

doi: 10.1016/j.semnephrol.2009.03.010

Seminars in Nephrology
Volume 29, Issue 4 , Pages 338-348 , July 2009

Article Tools